Prognostic factors in non-small cell lung cancer: multiregression analysis in the National Cancer Center Hospital (Japan)
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Prognostic Factors for Survival in Patients With Inoperable Lung Cancer<xref ref-type="fn" rid="FN2">2</xref>
1980 • 569 citations
Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules
1981 • 367 citations
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
1986 • 337 citations
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
1986 • 325 citations
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.
1986 • 242 citations
Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)
1982 • 120 citations
Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.
1985 • 109 citations
Treatment of non-small-cell lung cancer.
1986 • 97 citations
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
1985 • 81 citations
Importance of prognostic factors in cancer clinical trials.
1984 • 78 citations
Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer
1986 • 46 citations
Illusion and reality: practical pitfalls in interpreting clinical trials.
1984 • 41 citations
Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
1983 • 32 citations
Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
1986 • 29 citations
Effect of peplomycin plus carbazilquinone and mitomycin on non-small cell carcinoma of the lung.
1983 • 9 citations
Cited By (0)
No citing papers found in database